Ewa Golańska

917 citations
30 papers · 535 indexed · h-index 14
Topics
Prion Diseases and Protein Misfolding (13 papers)Alzheimer's disease research and treatments (6 papers)Neurological diseases and metabolism (5 papers)

In The Last Decade

Ewa Golańska

30 papers receiving 528 citations

Peers

Ewa Golańska
Comparison fields: 5 of 66
  • Molecular Biology 383
  • Neurology 147
  • Physiology 113
  • Neurology 89
  • Nutrition and Dietetics 71
Replace Ichiro Nozaki with:
Ichiro Nozaki Japan
Malene Ambjørn Denmark
Hanna Mierzewska Poland
Elena Panzeri Italy
Karin Seid Germany
Juraj Sepčić Croatia
Xiao-Hong Lin China
Elisa Maggioli Italy
M. Miyazono Japan
Asako Takanohashi United States
Ewa Golańska relative to Ichiro Nozaki Japan Ichiro Nozaki's profile →
Citations per field
00.5×1.5×2.1×
Ichiro Nozaki · 1×
Citations per year

Countries citing papers authored by Ewa Golańska

Since Specialization
Citations

This map shows the geographic impact of Ewa Golańska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Golańska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Golańska more than expected).

Fields of papers citing papers by Ewa Golańska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Golańska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Golańska. The network helps show where Ewa Golańska may publish in the future.

Co-authorship network of co-authors of Ewa Golańska

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Golańska. A scholar is included among the top collaborators of Ewa Golańska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Golańska. Ewa Golańska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 21
2 13
3 29
4 2
5 74
6 6
7 12
8 6
9 13
10 42
11 17
12 8
13 12
14 10
15 7
16 12
17 23
18 19
19
Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
44
20 35

About Ewa Golańska

Ewa Golańska is a scholar working on Neurology, Genetics and Molecular Biology, having authored 30 papers that have together received 535 indexed citations. Recurring topics across this work include Prion Diseases and Protein Misfolding (13 papers), Alzheimer's disease research and treatments (6 papers) and Neurological diseases and metabolism (5 papers). The work is most often cited by research in Neurology (147 citations), Neurology (89 citations) and Molecular Biology (383 citations). Ewa Golańska has collaborated with scholars based in Poland, Germany and United States. Frequent co-authors include Paweł P. Liberski, Piotr Rieske, Małgorzata Szybka, Inga Zerr, Franc Llorens, Beata Sikorska, Matthias Schmitz, Maria Barcikowska, Maria Styczyńska and Beata Pepłońska. Their work appears in journals such as PLoS ONE, Neurology and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026